Peer-influenced content. Sources you trust. No registration required. This is HCN.
Consultant360
The recent FDA approval of cantharidin introduces a novel topical treatment for molluscum contagiosum in patients aged 2 and above, presenting a significant stride in dermatological solutions.
Dermatology August 9th 2023
JAMA Network
Recent findings suggest a potential association between the school calendar and suicidality rates among children and adolescents, especially in light of disruptions observed during the COVID-19 pandemic.
Emergency Medicine August 8th 2023
The New England Journal of Medicine
This review delves into the neurological consequences of preterm birth, highlighting the particular brain impairments and developmental obstacles that survivors experience. Learn about the most recent advances in advanced neuroimaging and potential treatments to improve outcomes.
Neurology August 8th 2023
Medical Professionals Reference (MPR)
The potential shortage of Saxenda (liraglutide) through 2023 underscores the importance of monitoring the availability of this weight management drug. Physicians should be aware of this situation and consider alternative options if necessary.
Endocrinology, Diabetes, Metabolism August 3rd 2023
Pharmacy Today
The recent ban on gender-affirming care for minors in Texas underscores the urgent need for pharmacists to act as knowledgeable allies and advocates for transgender patients. Your role in education, advocacy, and trust-building is now more crucial than ever; learn more about how you can help.
Clinical Pharmacology July 31st 2023
The FDA’s approval of Beyfortus offers a promising tool for RSV disease prevention in neonates and young children. This novel intervention, underscored by robust clinical trial data, marks a crucial stride towards protecting infant health in the US.
Pediatrics July 27th 2023